Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.0092 | 0.8 |
mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.0089 | 0.8 |
mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.0078 | 0.8 |
mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | -0.0092 | 0.8 |
mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | 0.0091 | 0.8 |
mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.0088 | 0.8 |
mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | -0.009 | 0.8 |
mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.8 |
mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | 0.0077 | 0.8 |